Literature DB >> 69146

Effect of insulin antibodies on free and total plasma-insulin.

A B Kurtz, B E Mustaffa, P R Daggett, J D Nabarro.   

Abstract

Insulin administration often causes the development of insulin antibodies. Plasma insulin-binding capacity was assessed and free and total plasma insulin were measured in 96 insulin-dependent diabetic patients. Patients with the highest insulin binding capacity not only had the highest total insulin but also had the lowest free insulin. It is concluded that bound insulin is not unavailable to cells, that sufficient dissociation can occur for this insulin source to make a sizeable contribution to insulin delivery to the cell receptors, and that this can happen at a very low free insulin concentration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69146     DOI: 10.1016/s0140-6736(77)90062-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

Authors:  R Giannarelli; P Marchetti; M Giannecchini; G Di Cianni; P Cecchetti; A Masoni; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

2.  Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabetics.

Authors:  S Madsbad; C Gluud; P Bennett; T Krarup
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

3.  Insulin-binding antibody: reaction differences with bovine and porcine insulins.

Authors:  A B Kurtz; J A Matthews; J D Nabarro
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

4.  Modern management of the insulin dependent diabetic.

Authors:  R Tattersall
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

Review 5.  Insulin antibody determination: theoretical and practical considerations.

Authors:  W G Reeves
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

6.  Highly purified insulins.

Authors:  K G Alberti; M Nattrass
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

7.  Development and significance of antibodies to salmon calcitonin in patients with Paget's disease on long-term treatment.

Authors:  N J Woodhouse; S M Mohamedally; F Saed-Nejad; T J Martin
Journal:  Br Med J       Date:  1977-10-08

8.  The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes.

Authors:  Torben Biester; Thekla von dem Berge; Line Quist Bendtsen; Mette Dahl Bendtsen; Naveen Rathor; Thomas Danne; Hanne Haahr
Journal:  Pediatr Diabetes       Date:  2020-05-05       Impact factor: 4.866

9.  Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus.

Authors:  Hanne Haahr; Thomas R Pieber; Chantal Mathieu; Theis Gondolf; Masanari Shiramoto; Lars Erichsen; Tim Heise
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.